Swiss biopharma company Obseva has raised a CHF 60m series-B from HBM Partners and other investors.
Danish tech startup has so far raised €6m over three seed rounds
No-coding enterprise software company has seen engagement double during the coronavirus pandemic
Funds target the technology industry, with a focus on software, financial technology and healthcare IT
Acquisition aims to boost Capza's growth capital offering ahead of the launch of its growth fund